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Macrophage	accumulation	participates	decisively	in	the	development	and	exacerbation	of	atherosclerosis.	
Circulating	monocytes,	the	precursors	of	macrophages,	display	heterogeneity	in	mice	and	humans,	but	their	
relative	contribution	to	atherogenesis	remains	unknown.	We	report	here	that	the	Ly-6Chi	monocyte	subset	
increased	dramatically	in	hypercholesterolemic	apoE–deficient	mice	consuming	a	high-fat	diet,	with	the	num-
ber	of	Ly-6Chi	cells	doubling	in	the	blood	every	month.	Ly-6Chi	monocytes	adhered	to	activated	endothelium,	
infiltrated	lesions,	and	became	lesional	macrophages.	Hypercholesterolemia-associated	monocytosis	(HAM)	
developed	from	increased	survival,	continued	cell	proliferation,	and	impaired	Ly-6Chi	to	Ly-6Clo	conversion	
and	subsided	upon	statin-induced	cholesterol	reduction.	Conversely,	the	number	of	Ly-6Clo	cells	remained	
unaffected.	Thus,	we	believe	that	Ly-6Chi	monocytes	represent	a	newly	recognized	component	of	the	inflam-
matory	response	in	experimental	atherosclerosis.
Introduction
During atherogenesis, an inflammatory process, leukocytes and 
lipids accumulate in the aortic intima (1, 2). Lipid-rich macro-
phages, known as foam cells in atheromata, secrete inflammatory 
mediators that stimulate smooth muscle cell migration and pro-
liferation and participate in plaque development and rupture as 
well as thrombosis. Serum C-reactive protein and other molecular 
mediators of inflammation have broadened our understanding of 
the disease by illustrating that peripheral blood can afford valu-
able prognostic information (3, 4). Leukocyte counts rise in ath-
erosclerotic patients. Yet, the extent to which circulating leukocyte 
subsets reflect the inflammatory response during atherogenesis 
remains less defined (5–9). This study tested the hypothesis that 
leukocyte heterogeneity in atherosclerosis could provide novel 
markers of and mechanistic insights into atherogenesis.
Prevailing concepts view monocytes as intermediary cells that 
continuously develop in the bone marrow, circulate in the blood-
stream, and migrate unselected into tissue, where they become 
macrophages, dendritic cells, or other tissue descendants (10–12). 
Studies in atherosclerotic mice have shown that bone marrow–
derived circulating monocytes populate atherosclerotic lesions 
(13–17), and many studies support an active role for monocytes/
macrophages in atherosclerosis (reviewed in refs. 1, 2). The appre-
ciation of monocyte heterogeneity (18–20) has led to the hypoth-
esis that monocytes commit for specific functions while still in 
the circulation. Indeed, both human and mouse monocytes fall 
into at least 2 phenotypically distinct subsets: Ly-6Chi (which are 
also phenotypically Gr-1+CCR2+CX3CR1lo) and Ly-6Clo (which are 
also phenotypically Gr-1–CCR2–CX3CR1hi) mouse monocytes cor-
respond to human CD14hiCD16– and CD14+CD16+ monocytes, 
respectively (19, 21–24). Ly-6Chi cells selectively populate sites of 
experimentally induced inflammation, while their Ly-6Clo coun-
terparts can enter lymphoid and nonlymphoid tissues under 
homeostatic conditions (24).
This study explored Ly-6Chi and Ly-6Clo monocytes in atheroscle-
rotic mice. The results show that hypercholesterolemia induced a 
surprisingly profound expansion of blood Ly-6Chi but not Ly-6Clo 
monocytes, a process we termed hypercholesterolemia-associated 
monocytosis (HAM). Our results also establish a direct link between 
circulating Ly-6Chi monocytes and lesional macrophages.
Results
Hypercholesterolemic apoE–/– mice undergo gradual and systemic monocy-
tosis of the Ly-6Chi subset. To test the hypothesis that high-fat feeding 
alters the repertoire of circulating monocytes, we analyzed periph-
eral blood mononuclear cells from C57BL/6 wild-type (referred to 
as apoE+/+) and apoE–/– mice that consumed either regular chow or 
Western diet (high in cholesterol and fat) for 25 weeks. Monocytes 
were defined as CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo 
mononuclear cells by flow cytometry, as previously reported (16), 
and further divided into Ly-6Chi and Ly-6Clo fractions (Figure 1A).   
apoE–/– mice on Western diet had a 4-fold increase of total circu-
lating monocytes when compared with the same mice on chow 
(Figure 1B). Monocytosis in apoE–/– mice on Western diet resulted 
from a 14-fold increase of the Ly-6Chi subset (Figure 1C), whereas 
the Ly-6Clo population remained unchanged (Figure 1D). Con-
sumption of a Western diet increased slightly the number of 
total circulating leukocytes in apoE–/– mice (mean ± SEM, chow,   
3.0 ± 0.5 × 106 cells/ml; Western diet, 3.9 ± 0.4 × 106 cells/ml; Figure 1E).   
Blood smear counts showed that this increase arose primarily 
from monocytes (chow, 0.14 ± 0.03 × 106 cells/ml; Western diet,   
0.94 ± 0.11 × 106 cells/ml), although granulocytes also increased (chow, 
Nonstandard	abbreviations	used: AcLDL, acetylated low-density lipoprotein; 
CCR2, C-C motif chemokine receptor 2; CD62L, CD62 ligand; HAM, hypercholester-
olemia-associated monocytosis; MHEC, mouse heart EC.
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0.27 ± 0.03 × 106 cells/ml; Western diet, 0.96 ± 0.11 × 106 cells/ml)   
and lymphocytes decreased slightly (chow, 2.4 ± 0.6 × 106 cells/ml;   
Western diet, 2.0 ± 0.2 × 106 cells/ml). As expected (25, 26),   
apoE–/– mice on Western diet had increased serum cholesterol lev-
els (479 ± 20 mg/dl) when compared with apoE–/– mice on chow 
(286 ± 25 mg/dl).	Macroscopic and histologic examination of   
aortas revealed fatty streaks and fibrous plaque lesions in the root 
and descending aorta of apoE–/– mice regardless of diet. Lesions 
were identified along the entire aorta in older mice (i.e., mice that 
consumed Western diet for 50 weeks; data not shown). apoE–/– mice 
consuming Western diet had 3–5 times more extended and wide-
spread atherosclerotic lesions than did apoE–/– mice on chow.
Figure 1
Hypercholesterolemia induces peripheral blood Ly-6Chi monocytosis. (A) Mononuclear cells from blood of apoE+/+ and apoE–/– mice consuming 
either chow or Western diet were stained with anti-CD11b, -CD90, -B220, -CD49b, -NK1.1, –Ly-6G, and –Ly-6C mAbs. Living cells were gated 
to determine presence and percentage of CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo monocytes (top row) and further divided into Ly-6Chi 
and Ly-6Clo subsets (bottom row). Representative dot plots and histograms from individual mice are depicted. Percentages of cells are shown 
as mean ± SEM. (B) Total blood monocytes in apoE+/+ and apoE–/– mice consuming either Western diet (+) or chow (–). (C) Total blood Ly-6Chi 
monocytes. (D) Total blood Ly-6Clo monocytes. (E) Total peripheral blood leukocytes. (F) Representative dot plots depicting expression of CD62L 
and CD11c among Ly-6Chi and Ly-6Clo monocytes. Percentages of cells in each quadrant are shown as mean ± SEM. (G) Representative cyto-
spin preparations of purified blood Ly-6Chi and Ly-6Clo monocytes in apoE+/+ mice on chow and apoE–/– mice on Western diet. Scale bar: 10 μm. 
Student’s t test was used. Results are representative of 8 independent experiments with 5–14 mice per group.research article
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apoE+/+ mice fed a Western diet had serum cholesterol levels of   
227 ± 39 mg/dl, lower than those observed in apoE–/– mice on Western 
diet but higher than those in apoE+/+ mice on chow (101 ± 10 mg/dl). 
apoE+/+ mice fed a Western diet did not show a significant increase 
in the number of circulating monocytes or Ly-6Chi monocytes   
(Figure 1, B–D) and did not develop atherosclerotic lesions during 
the 25 weeks of diet consumption (data not shown).
apoE–/– mice also had elevated numbers of CD11b+CD90+B220+
CD49b+NK1.1+Ly-6C+ cells (chow, 3.0% ± 0.1% cells; Western diet, 
3.8% ± 0.4% cells) than apoE+/+ mice (chow, 1.8% ± 0.3% cells; West-
ern diet, 1.9% ± 0.2% cells). These cells were phenotypically distinct 
from monocytes and were not examined further.
Although the number of circulating monocytes increased dra-
matically in apoE–/– mice fed Western diet, Ly-6Chi cells consis-
tently expressed CD62 ligand (CD62L; also known as L-selec-
tin) but not CD11c, while Ly-6Clo cells consistently expressed 
low levels of CD11c but not CD62L (Figure 1F), as previously 
reported for these monocyte subsets (21). Morphologic analy-
sis of flow-sorted cells also showed that cells of both subsets 
retained their size as well as their characteristic kidney- or horse-
shoe-shaped nuclei (Figure 1G).
Having determined that numbers of circulating monocytes 
increased in apoE–/– mice on Western diet, we assessed the spa-
tial and temporal course of monocytosis development by quan-
tification of monocytes and their subsets in the bone marrow, 
peripheral blood, and spleen over 250 days of Western diet con-
sumption (Figure 2A). Analysis included additional compart-
ments because the bone marrow produces monocytes and the 
spleen may serve as a reservoir for monocytes in the periphery. 
Monocytosis developed progressively in all 3 compartments, 
and the blood and spleen showed predominant expansion of 
the Ly-6Chi subset. Statistical analysis matched the data to an 
exponential growth curve, permitting determination of dou-
bling time for each tissue. The Ly-6Chi subset showed the low-
est doubling times (95% confidence interval, 33 to 38 days in 
the blood), while, as expected, the Ly-6Clo monocyte subset had 
the highest doubling times (95% confidence interval, 145 to 256 
days in the blood).
Figure 2
Peripheral blood monocytosis develops over the course of 250 days on an atherogenic diet. (A) Number of total monocytes and Ly-6Chi and 
Ly-6Clo subtypes in bone marrow, blood, and spleens of apoE–/– mice at various days of Western diet. Statistical analysis was based on an expo-
nential growth curve and known cell numbers on day 0. Curve fit (solid line) and 95% confidence intervals (dashed lines) are shown. Doubling 
time (DT) of cell number is shown. (B) The same analysis was conducted with peripheral blood from apoE+/+ and apoE–/– mice that remained 
on chow diet. Doubling time of cell number in days is shown. (C) Splenic CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo cells were divided into 
F4/80hiCD11chiI-Ab–high macrophages/dendritic cells (gate i) and F4/80loCD11cloI-Ab–low monocytes, which were further divided into Ly-6Clo 
(gate ii) and Ly-6Chi (gate iii) subsets. These 3 subsets were isolated and stained with HEMA 3 for microscopic analysis. Scale bar: 10 μm. 
Results are pooled from 8 independent experiments.research article
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Control experiments used blood from apoE+/+ and apoE–/– mice 
during 250 days of chow consumption (Figure 2B). apoE+/+ mice 
on chow did not develop monocytosis, excluding the possibility 
that age drives the increase. apoE–/– mice on chow showed moder-
ate monocytosis. Statistical analysis matched the data to an expo-
nential growth curve, though doubling times (e.g., 95% confidence 
interval, 63 to 86 days for Ly-6Chi monocytes in the blood) were 
1.9–2.3 times longer than in apoE–/– mice on Western diet. Thus, 
atherosclerosis and Ly-6Chi monocytosis arise concomitantly in 
apoE–/– mice and show aggravation by Western diet.
Although we used the same criteria to define monocytes in the 
bone marrow and spleen as in blood (e.g., the CD11bhiCD90loB
220loCD49bloNK1.1loLy-6Glo phenotype), the preponderance of 
macrophages and dendritic cells in the spleen necessitated a sec-
ondary step to ensure that the cells were indeed monocytes. In the 
spleen, monocytes were further defined as F4/80loCD11cloI-Ab– 
low. These cells had the same morphology as blood monocytes, 
whereas cells positive for F4/80, I-Ab, and/or CD11c resembled 
macrophages  or  dendritic 
cells (Figure 2C). Because of 
the low number of monocytes 
in the blood, the spleen there-
fore furnished a rich source 
of mononuclear cells for fur-
ther study.
Monocytosis  results  from 
increased survival, continued pro-
liferation and impaired Ly-6Chi to 
Ly-6Clo conversion. Given that 
the progressive and peripher-
al monocytosis of the Ly-6Chi 
subset in apoE–/– mice was 
most robust during consump-
tion of Western diet, we next 
sought to determine whether 
a model modified lipoprotein, 
such as acetylated low-density 
lipoprotein (AcLDL), directly 
influences monocyte survival 
and/or proliferation. Initially, 
splenic Ly-6Chi and Ly-6Clo 
monocytes from apoE–/– mice 
on Western diet were isolated 
and cultured for 24 hours in 
medium supplemented or not 
with 100 μg/ml AcLDL. The 
presence of AcLDL allowed 
Ly-6Chi  cells  to  survive   
(Figure 3A) while retaining 
their monocytic Ly-6ChiF4/
80loCD11cloI-Ab–low pheno-
type. Conversely, survival of 
Ly-6Clo cells did not change in 
the presence of AcLDL (data 
not  shown).  Because  LDL 
can induce aortic endothelial 
cells to synthesize and secrete   
M-CSF (27), we assessed wheth-
er this factor can also influence 
the fate of monocytes in vitro. 
Supplementation of medium with M-CSF (50 μg/ml) for 24 hours 
partially fostered Ly-6Chi monocyte survival (Figure 3A).
These data suggest that LDL and/or its derivatives directly and 
indirectly promote the survival of Ly-6Chi monocytes. Neverthe-
less, the in vitro conditions used may not reproduce the in vivo 
environment in apoE–/– mice on Western diet, since the number of 
Ly-6Chi monocytes did not increase in vitro. Therefore, we sought 
to compare directly the proliferation and survival of monocytes 
in vivo. apoE–/–animals consuming either chow or Western diet 
received daily i.p. injections of BrdU for 3 days and were sacrificed 
1 day later. Mononuclear cells were purified from the bone mar-
row, blood, and spleen, and monocytes were analyzed for apop-
tosis (annexin V) and proliferation (anti-BrdU mAb). The West-
ern diet decreased the number of annexin V+ cells within Ly-6Chi 
monocytes in the bone marrow and peripheral blood but not in 
the spleens of apoE–/– mice (Figure 3, B and C). The Western diet 
concurrently increased the number of BrdU+ cells within Ly-6Chi 
monocytes in peripheral blood and the spleen (Figure 3, B and C). 
Figure 3
Ly-6Chi monocytosis results from increased survival, continued proliferation, and impaired Ly-6Chi to Ly-6Clo 
monocyte conversion. (A) Ly-6Chi monocytes from the spleens of apoE–/– mice were placed into culture with 
medium alone or medium supplemented with 100 μg/ml AcLDL or 50 μg/ml M-CSF. The percentage of cells 
alive 24 hours later was calculated based on the ratio of retrieved and input cell numbers. **P < 0.01, *P < 0.05 
versus medium alone (1-way ANOVA with Tukey’s multiple comparison test). (B) apoE+/+ and apoE–/– mice 
on chow and Western diet received 3 i.p. injections of BrdU on 3 consecutive days. Cells from bone marrow, 
blood, and spleen were collected 1 day after the last injection and labeled with annexin V or anti-BrdU mAb. 
Results are shown for gated CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo monocytes as identified in Figure 1.   
Statistical analyses were performed using Student’s t test. (C) Representative dot plots depicting annex-
in V staining and BrdU incorporation in splenic CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo monocytes 
from apoE+/+ and apoE–/– mice on chow and Western diet. (D) apoE–/– mice on chow and Western diet 
received clodronate liposomes on day 0. Representative contour plots depict Ly-6C versus F4/80/I-Ab/CD11c   
phenotype among splenic CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo monocytes on days 1 and 5 or in 
age-matched untreated mice. (E) Percent of splenic Ly-6Clo monocytes recovered after clodronate liposome 
injection in apoE–/– mice on chow and Western diet compared with absolute number of cells in age-matched 
untreated mice. Shown are 1 of 2–3 independent experiments.research article
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The vast majority of bone marrow monocytes incorporated BrdU 
regardless of diet, likely reflecting the continuous medullary pro-
duction of these cells. These observations reflect the increased 
survival of dividing Ly-6Chi monocytes in apoE–/– mice consum-
ing Western diet, but may result from accelerated production in 
the bone marrow and/or from increased extramedullary prolif-
eration. Interestingly, the higher levels of BrdU incorporation by 
Ly-6Chi monocytes in the spleen (mean fluorescence intensity, 
528 ± 111) compared with the bone marrow (mean fluorescence 
intensity, 293 ± 63) indicate either continued proliferation in the 
periphery or selective emigration from the bone marrow of cells 
with longer proliferative histories.
Analysis  of  apoptosis  and  proliferation  in  apoE+/+  mice 
showed that Western diet increased survival and proliferation of 
monocytes in the spleen but not in the bone marrow or blood 
(Figure 3, B and C). Because apoE regulates apoptosis and cell 
cycle (28, 29), it may participate in the differences observed 
between apoE+/+ and apoE–/– mice.
To determine whether the Western diet also affects conversion of 
Ly-6Chi to Ly-6Clo monocytes, apoE–/– mice on chow and Western 
diet received clodronate liposomes to deplete endogenous circulat-
ing monocytes (24). Mice administered clodronate liposomes had 
a dramatically reduced number of Ly-6CloF4/80loCD11cloI-Ab–low 
monocytes in blood (chow, 0.6 ± 0.2 × 104 versus 8.7 ± 4.6 × 104 
cells/ml; Western diet, 1.1 ± 0.6 × 104 versus 9.6 ± 1.3 × 104 cells/ml) 
and spleen (chow, 2.4 ± 1.1 × 104 versus 32.5 ± 7.3 × 104 cells/ml; 
Western diet, 3.8 ± 0.9 × 104 versus 381.0 ± 84.2 × 104 cells/ml) 1 day 
after injection. Clodronate also strongly reduced the number of 
Ly-6CloF4/80hiCD11chiI-Ab–high macrophages/dendritic cells and 
moderately reduced the number of Ly-6ChiF4/80loCD11cloI-Ab– 
low monocytes (Figure 3D and data not shown). The near absence 
of Ly-6Clo monocytes on day 1 allowed us to study their reemer-
gence from the Ly-6Chi repertoire (Figure 3, D and E). Five days 
after clodronate injection, Ly-6Clo monocytes had repopulated 
both blood and spleen in animals on chow but not in animals 
consuming Western diet (Figure 3, D and E, and data not shown). 
Impaired Ly-6Chi to Ly-6Clo conversion in apoE–/– mice consuming 
Western diet fostered Ly-6Chi monocytosis.
Ly-6Chi monocytes accumulate selectively in atherosclerotic lesions. 
Adoptively transferred EGFP+ monocytes accumulate in athero-
sclerotic lesions (16), but low numbers of EGFP+ signals detected 
by immunohistochemistry prevent quantification of cell accumu-
lation. Here we employed a recently established flow cytometry 
method (30) to phenotype single-cell suspensions of enzyme-
digested aortas and determined the in vivo relevance of Ly-6Chi 
monocytosis to atherosclerosis. Aortas from apoE+/+ and apoE–/–   
animals on either chow or Western diet contained at least 2 dis-
tinct populations of cells expressing CD11b, identified in gate 
i as putative monocytes and in gate ii as putative macrophages 
(Figure 4, A and B). Cells detected in gate i fell into 4 pheno-
typically distinct populations: Ly-6ChiF4/80loCD11cloI-Ab–low,   
Ly-6ChiF4/80+CD11c+I-Ab–positive, Ly-6CintF4/80+CD11c+I-Ab–
positive, and Ly-6CloF4/80loCD11cloI-Ab–low, resembling circu-
lating Ly-6Chi monocytes, monocytes in the process of differen-
tiation, differentiated macrophages and/or dendritic cells, and 
Ly-6Clo monocytes, respectively (Figure 4A).
Enumeration showed 3,280 ± 240 Ly-6ChiF4/80loCD11cloI-Ab–
low monocytes in the aortas of apoE–/– mice on Western diet, but 
only 580 ± 20 in the aortas of apoE–/– mice on chow. By compari-
son, aortas showed few Ly-6CloF4/80loCD11cloI-Ab–low monocytes 
(580 ± 70 and 500 ± 90 cells in apoE–/– mice on Western diet and 
chow, respectively; Figure 4B). Thus Western diet selectively 
increased Ly-6Chi monocyte accumulation in atherosclerotic aortas 
of apoE–/– mice. As expected, aortas contained more macrophages 
Figure 4
Atherosclerotic lesions contain Ly-6Chi   
monocytes. (A) Aortas from apoE+/+ 
and apoE–/– mice on chow and West-
ern diet were digested with a protease 
cocktail. Cells were dispersed and 
stained  with  anti-CD11b,  -CD90,   
-B220, -CD49b, -NK1.1, –Ly-6G, -F4/80,   
–I-Ab, -CD11c, and –Ly-6C mAb. Per-
cent (mean ± SEM) are shown for each 
quadrant. (B) Number of retrieved   
Ly-6Chi and Ly-6Clo monocytes per 
aorta in apoE+/+ and apoE–/– mice on 
chow and Western diet. Results are 
pooled from 5 independent experi-
ments with 2–5 mice per group. Mean 
and SEM are shown. #P < 0.001 ver-
sus all other groups (1-way ANOVA 
with Tukey’s multiple comparison test). 
(C) Immunohistochemistry depicts the 
intima at the aortic root of a represen-
tative apoE–/– mouse on Western diet 
and an apoE+/+ mouse on chow. Sec-
tions stained with anti-CD31, –Ly-6C, 
and –Mac-3 mAbs are shown. Original 
magnification, ×400.research article
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and/or dendritic cells in apoE–/– mice on Western diet (gate ii;   
4.9 ± 1.7 × 104 cells) than on chow (1.1 ± 0.3 × 104 cells).
We counted relatively low numbers of Ly-6Chi and Ly-6Clo 
monocytes and macrophages/dendritic cells in the aortas of apoE+/+ 
mice regardless of diet (Western diet, 260 ± 10 Ly-6Chi monocytes, 
310 ± 160 Ly-6Clo monocytes, 1.3 ± 0.5 × 104 macrophages/den-
dritic cells; chow, 220 ± 170 Ly-6Chi monocytes, 230 ± 120 Ly-6Clo 
monocytes, 1.2 ± 0.3 × 104 macrophages/dendritic cells; Figure 4B).
The above cell numbers likely underestimate actual values, since 
the enzymatic digestion of aortic tissue required to obtain single-
cell suspensions caused the death of many cells (90% ± 1% of events 
contributed to debris and dead cells, as defined by 
low forward scatter) that were excluded from the 
analysis. The actual difference in Ly-6Chi and Ly-6Clo   
monocyte numbers is overestimated if Ly-6Clo 
monocytes are more likely to die during isolation.
We performed immunohistochemical examina-
tion of aortic roots isolated from the apoE–/– mice 
described above to evaluate the spatial distribu-
tion of Ly-6Chi cells in severe (fibrous plaque) and 
early (fatty streak) lesions (Figure 4C and data not 
shown). Ly-6C colocalized with mononuclear-like 
cells on the intimal face of CD31+ endothelial cells 
but not with the bulk of Mac-3+ macrophage-rich 
areas in both types of lesions. These observations 
suggest that Ly-6Chi monocytes migrate to early 
and severe lesions and that	differentiation into 
macrophages accompanies transmigration into 
the artery, although some Ly-6Chi monocytes may 
reside in the innermost layer of the intima. The 
relative number of Ly-6Chi cells compared with the 
number of Mac-3+ cells in these regions was 4.8 
times higher in severe than in early lesions, sug-
gesting that Ly-6Chi monocytes migrate more effi-
ciently to severe lesions.
Ly-6Chi monocytes adhere preferentially to activated 
endothelium, accumulate in atherosclerotic plaques, and 
rapidly become lesional macrophages. Further examina-
tion followed the activity and fate of Ly-6Chi and 
Ly-6Clo monocytes isolated from either apoE–/– or 
apoE+/+ mice on Western diet or chow. More than 
70% of the cells remained alive in culture 24 hours 
after the isolation procedure (data not shown) and 
preserved monocytic markers (i.e., Ly-6Chi or Ly-6Clo,   
CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo, and 
F4/80loCD11cloI-Ab–low; Figure 5A). We initially 
determined the capacity of monocyte subsets to 
adhere to TNF-α–activated murine cardiac endo-
thelium under laminar flow conditions. Freshly iso-
lated blood Ly-6Chi monocytes from apoE–/– mice 
on either Western diet or chow adhered efficiently 
to the endothelium within minutes, while Ly-6Clo 
cells adhered significantly less well (Figure 5B, white 
bars), as did naive lymphocytes (data not shown). 
Similar results were observed with monocytes iso-
lated from apoE+/+ mice (Figure 5B, black bars). 
These results indicate that Ly-6Chi monocytes 
adhere preferentially to activated endothelium 
independent of diet or of the presence or absence of 
apoE. The relative proportion of circulating Ly-6Chi 
and Ly-6Clo monocyte subsets in apoE–/– mice on Western diet sug-
gests that greater than 95% of cells capable of binding to activated 
endothelium would belong to the Ly-6Chi subset (Figure 5C).
Further exploration used adoptive transfer of Ly-6Chi monocytes 
from CD45.2 apoE–/– mice into congenic CD45.1 apoE–/– recipi-
ents (both donor and recipient mice on Western diet for 25 
weeks). Because peripheral blood contains few monocytes, splenic 
monocytes served as surrogates for circulating monocytes. After 
24 hours, aortas from recipient mice were digested enzymatically, 
and single-cell suspensions were analyzed by flow cytometry. We 
counted 135 ± 4 donor cells in recipient aortas, of which approxi-
Figure 5
Ly-6Chi monocytes adhere preferentially to TNF-α–activated endothelium, accumulate 
in lesions, and differentiate to macrophages in vivo. (A) Purified Ly-6Chi monocyte 
phenotype after 24 hours in culture. (B) Adherence of blood monocytes on TNF-α–
treated MHECs under laminar flow conditions. Monocyte subsets were isolated from 
the blood of apoE+/+ and apoE–/– mice on chow and Western diet. (C) Relative propor-
tion of blood monocytes expected to adhere to activated endothelium, based on the 
capacity of each subset to adhere and their average abundance in peripheral blood of 
apoE–/– mice on Western diet for 25 weeks. (D) Ly-6C, F4/80, and I-Ab expression of 
CD45.2+ Ly-6Chi monocytes retrieved from aortas and spleens 24 hours after trans-
fer into CD45.1+ mice (both donor and recipient apoE–/– mice consuming a Western 
diet). Monocytes cultured in vitro were also analyzed. (E) F4/80 and Ly-6C coexpres-
sion on CD45.2+ donor cells retrieved from aortas. (F) In vivo aortic accumulation of 
[111In]oxine-labeled Ly-6Chi and Ly-6Clo monocytes 24 hours after adoptive transfer 
in apoE–/– mice on Western diet. (G) Phosphorimager plates depicting relative dis-
tribution of signal in aortas of apoE–/– mice that received equal numbers of Ly-6Chi 
apoE–/– or Ly-6Clo apoE–/– monocytes. (H) Relative proportion of Ly-6Chi and Ly-6Clo 
monocytes expected to accumulate in atherosclerotic aortas, based on the capacity of 
each subset for aortic accumulation and their average abundance in peripheral blood 
of apoE–/– mice on Western diet for 25 weeks. Shown are 1 of 2–3 independent experi-
ments. Student’s t test was used.research article
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mately 25% were Ly-6Chi and approximately 75% were Ly-6Clo   
(Figure 5D). Many donor cells showed enhanced expression of 
F4/80 and I-Ab (Figure 5D). Remarkably, the combined analysis of 
Ly-6C and F4/80 expression by donor cells revealed the existence 
of at least 3 distinct populations, Ly-6ChiF4/80–, Ly-6ChiF4/80+, 
and Ly-6CloF4/80+, resembling monocytes, monocytes in the 
process of differentiating into macrophages, and mature macro-
phages, respectively (Figure 5E). These phenotypic relationships 
are comparable to those observed among endogenous populations   
(Figure 4A). In contrast, donor cells retrieved from the spleens of the 
same mice remained phenotypically unchanged (Figure 5D). These 
results demonstrate recruitment of Ly-6Chi monocytes to athero-
sclerotic aortas, followed by local and rapid (<24 hours) differentia-
tion into macrophages. Combined with the restricted localization 
of Ly-6Chi monocytes to the luminal face of the endothelium, these 
data suggest that differentiation into macrophages accompanies 
transmigration and also support the notion that aortic monocyte 
detection did not result from contamination of circulating cells.
To determine the relative capacity of Ly-6Chi and Ly-6Clo 
monocytes to migrate to atherosclerotic aortas and to determine 
whether accumulation of Ly-6Chi cells mapped to lesions, we 
labeled equal numbers of splenic Ly-6Chi and Ly-6Clo monocytes 
from apoE–/– mice on Western diet with [111In]oxine and inject-
ed them separately into apoE–/– mice on Western diet. After 24 
hours, we excised the aortas and calculated the percent injected 
dose per gram of tissue, which revealed that Ly-6Chi cells pref-
erentially accumulated in aortas (Figure 5F). Autoradiography 
showed discrete regions of activity only in recipients of Ly-6Chi 
cells (Figure 5G). The lack of such regions in animals receiving 
Ly-6Clo cells suggests that the signals detected in these mice 
corresponded to background activity. The radioactive signal 
observed for Ly-6Chi cells always mapped directly to areas con-
taining lesions as determined microscopically, but not all lesions 
showed focal areas of radioactivity (data not shown). The relative 
proportion of circulating Ly-6Chi and Ly-6Clo monocyte subsets 
in apoE–/– mice on Western diet suggests that greater than 90% 
of cells accumulating in atherosclerotic lesions originate from 
the Ly-6Chi subset (Figure 5H). Taken together, these results sug-
gest that circulating Ly-6Chi monocytes are direct precursors of 
lesional macrophages.
Expression of MCP-1 by a subset of cells in atherosclerotic 
lesions suggests active recruitment of monocytes to developing 
lesions in vivo (31, 32), and mice lacking MCP-1 or C-C motif che-
mokine receptor 2 (CCR2) show reduced atherosclerosis (33–35). 
Thus monocyte recruitment into lesions may require CCR2 expres-
sion, a feature of the Ly-6Chi subtype (19). Testing this hypothesis 
involved the adoptive transfer of Ly-6Chi monocytes from bone 
marrow of CCR2–/– mice into peripheral blood of atherosclerotic 
(CCR2+/+) apoE–/– mice. We counted only 14 ± 2 donor cells in 
recipient aortas, suggesting that Ly-6Chi monocyte accumulation 
in lesions does indeed depend on CCR2.
Statin administration attenuates Ly-6Chi monocytosis. Having shown 
that lesional macrophages were derived from circulating Ly-6Chi 
monocytes in atherosclerosis, we sought to determine whether 
Figure 6
Statin treatment limits monocytosis. apoE–/– 
mice consumed Western diet supplemented 
or not with atorvastatin for 25 weeks. A con-
trol group of apoE–/– mice received regular 
chow. (A) Serum cholesterol after 25 weeks 
of diet. (B) Number of leukocytes, monocytes, 
and Ly-6Chi and Ly-6Clo subtypes in bone 
marrow, blood, and spleen. (C) Association 
between serum cholesterol and number of 
circulating Ly-6Chi or Ly-6Clo monocytes 
after  25  weeks  of  diet.  Mean  ±  SEM   
are shown for apoE–/– mice on chow (filled 
circles), Western diet (open circles), and 
Western diet supplemented with atorvas-
tatin (gray circles). Results are pooled from 
9 independent experiments (n = 3–14 per 
group). Student’s t test was used.research article
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reduction of Ly-6Chi monocytosis attenuates disease. Repeated 
administration of anti–Ly-6C mAb could theoretically control 
Ly-6Chi monocytosis. This approach is impractical, given the 
chronic nature of atherogenesis, and may not keep the size of 
the Ly-6Chi monocyte population at homeostatic levels, but rath-
er trigger transient cell depletion upon each mAb injection. In 
contrast, since inhibitors of hydroxymethylglutaryl coenzyme A 
reductase (statins) decrease cholesterol levels, exert antiinflam-
matory effects, and attenuate atherosclerosis (36, 37), we sought 
to determine whether concurrent treatment of apoE–/– mice on 
Western diet with statin also modulates the extent of monocyto-
sis. Mice analyzed after 25 weeks of atorvastatin treatment had 
significantly attenuated serum cholesterol levels when compared 
with age-matched littermates on Western diet (Figure 6A). The 
statin treatment also reduced monocytosis (Figure 6B). Specifi-
cally, the numbers of Ly-6Chi monocytes declined significantly in 
the spleen and peripheral blood (although they remained higher 
than in apoE–/– mice on chow), whereas the numbers of Ly-6Chi 
monocytes in the bone marrow fell to levels found in apoE–/– mice 
on chow (Figure 6B). The statin treatment also reduced the num-
bers of the Ly-6Clo monocytes in the spleen.	Antiinflammatory 
effects of statins beyond LDL lowering could also participate in 
the attenuation of Ly-6Chi cell numbers.
Blood Ly-6Chi monocyte counts positively associated with 
serum cholesterol levels in apoE+/+ (data not shown) and apoE–/– 
mice (Figure 6C). Furthermore, correlation between Ly-6Chi num-
bers from statin-treated apoE–/– mice conformed to a linear axis 
between chow- and Western diet–fed animals. Such correlative 
analysis did not apply for blood Ly-6Clo monocytes, since Ly-6Clo 
cell counts were similar for all serum cholesterol concentrations.
Discussion
This study shows that hypercholesterolemia in apoE–/– mice 
induced the progressive and selective expansion of Ly-6Chi 
monocytes, a phenomenon we have termed HAM. Ly-6Chi 
monocytes participate in atherosclerosis because they preferen-
tially adhered to activated endothelium, accumulated in lesions, 
and locally differentiated into macrophages, the predominant 
leukocytes during plaque inflammation and development. 
Although we did not describe a role for Ly-6Clo cells in athero-
sclerosis, future studies may determine whether this subset, as a 
possible precursor of dendritic cells (38), influences the adaptive 
arm of the immune system, particularly with respect to antigen 
presentation and lymphocyte activation, processes known to 
occur in atherosclerosis (1).
HAM results from continued bone marrow production of Ly-6Chi 
monocytes, increased survival of these cells in the periphery, and 
impaired conversion to the Ly-6Clo subset. Monocytosis was char-
acterized by a doubling of the Ly-6Chi population every month in 
peripheral blood, generating up to 1.4 × 106 cells/ml after 250 days 
of diet; although the rate of Ly-6Chi monocytosis was slightly slow-
er in the spleen (doubling time of around 2 months), this organ 
served as a much larger reservoir of Ly-6Chi monocytes, reaching 
approximately 2 × 107 cells after 250 days of diet. Moreover, since 
the number of Ly-6Chi monocytes continuously increased during 
the 250 days of the study, monocyte expansion would likely have 
persisted beyond this point.
We suggest that Ly-6Chi monocytosis requires elevated concen-
trations of cholesterol or lipid derivatives, since (a) monocytosis 
occurred in mice fed Western diet, (b) the presence of a choles-
terol-lowering drug of the statin class at least partially controlled 
monocytosis in vivo, and (c) the addition of LDL for 24 hours to 
purified Ly-6Chi monocytes in vitro allowed for their increased 
survival without promoting differentiation into macrophages. 
These findings demonstrate that augmented serum cholesterol 
levels, in addition to promoting lipid deposition in lesions (39) 
and inducing M-CSF production for local monocyte maturation 
into macrophages (40, 41), also trigger the expansion of circulat-
ing monocytes. These data suggest that a cholesterol-rich diet pro-
motes murine atherogenesis, at least in part through the develop-
ment of monocytosis. Molecules such as M-CSF, GM-CSF, PI3K, 
and NF-κB are induced by constituents of modified LDL and 
mediate the expansion and maturation of macrophages (42, 43). 
It will be of interest to determine whether similar pathways also 
elicit Ly-6Chi monocytosis and why circulating Ly-6Clo monocytes 
appear less sensitive to the same stimuli.
Following the fate of adoptively transferred, purified mono-
cyte subsets revealed that lesional macrophages derived pre-
dominantly from circulating Ly-6Chi monocytes, pointing to 
an active role in this process for the membrane-bound, glyco-
sylphosphatidylinositol-linked protein Ly-6C (44–46). Future 
studies will show whether Ly-6C serves only as a marker for 
or also contributes functionally to inflammatory monocytes, 
whether Ly-6C characterizes inflammatory cells capable of tis-
sue transmigration, and whether therapeutic targeting of Ly-6C, 
or a human equivalent, contains monocytosis and consequently 
reduces atherosclerosis.
The observation that Ly-6Chi cells trafficked differentially to 
lesions supports the concept of heterogeneity of atheromata (47, 
48) and suggests that these cells migrate preferentially to lesions 
of high inflammatory activity. Interestingly, fatty streaks harbored 
few Ly-6Chi monocytes, indicating low monocyte accumulation at 
this stage. Expression of CD62L also suggests a role for Ly-6Chi 
monocytes in antigen presentation in secondary lymphoid organs 
and participation in adaptive immunity.
Activated macrophages, operationally categorized as M1 cells 
(classically activated macrophages), are induced by IFN-γ and 
generate inflammation, while M2 cells (alternatively activated 
macrophages) generated in response to IL-4 or IL-13 can exhibit 
immunoregulatory function (49, 50). Ly-6Chi monocytes selec-
tively populate sites of experimentally induced inflammation 
and can locally differentiate into M1 cells. However, whether the 
cytokine milieu recruits and/or activates specific monocyte sub-
sets, or indiscriminately polarizes already accumulated subsets for 
particular macrophage function will require further study.
Clinical data have shown a positive correlation between white 
blood cell count and acute myocardial infarction (5–7). More 
recently, a study showed that monocytosis is an independent risk 
factor for coronary artery disease (51). Here we propose that mono-
cytosis is an etiologic constituent of experimental atherogenesis. 
Future research will determine whether humans with elevated 
serum cholesterol and/or C-reactive protein exhibit CD14hiCD16– 
monocytosis, and whether this variable relates to atheroma burden 
or complications. Overall, our present results indicate a striking 
and dynamic alteration of the monocyte repertoire during experi-
mental atherogenesis, recognize circulating Ly-6Chi monocytes 
as key mediators of chronic inflammation, and suggest what we 
believe to be novel mechanistic hypotheses regarding the interface 
of innate immunity and atherosclerosis that will require future 
testing experimentally and in humans.research article
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Methods
Animals. apoE+/+ (C57BL/6) and apoE–/– (B6.129P2-Apoetm1Unc) mice were 
purchased from The Jackson Laboratory. The apoE–/– animals had been 
backcrossed to the C57BL/6 background for at least 10 generations. 
apoE–/– CD45.1+/+ mice were generated after backcrossing apoE–/– mice 
to C57BL/6 CD45.1+/+ mice (The Jackson Laboratory). C57BL/6 CCR2–/–   
mice were a gift from B. Rollins (Dana-Farber Cancer Institute, Boston, 
Massachusetts, USA), A. Luster (Massachusetts General Hospital and 
Harvard Medical School), and I. Charo (UCSF, San Francisco, California, 
USA). At 10 weeks of age, groups of animals were placed on a Western diet 
(21.2% fat/weight, 0.2% cholesterol; Harlan Teklad), which was defined 
as day 0 in this study. The remaining animals consumed a regular chow 
diet. A group of animals received supplemental atorvastatin in their diet 
(52) (0.01% w/w) starting on day 0. All studies were conducted with age-
matched animals after 20–25 weeks of diet unless otherwise stated. All 
protocols were approved by the Subcommittee on Animal Research Care 
(SARC) at Massachusetts General Hospital.
Cells. Cells were harvested from bone marrow, peripheral blood, 
spleens, and aortas at the time points indicated in Results. Bone marrow 
from both tibias was harvested, and the cells were collected by inserting 
a needle into the bone and washing with HBSS supplemented with 0.2% 
(w/v) BSA and 1% (w/v) FCS. Peripheral blood was drawn via cardiac 
puncture with citrate solution (100 mM Na-citrate, 130 mM glucose, 
pH 6.5) as anticoagulant, and mononuclear cells were purified by den-
sity centrifugation (16). Total leukocyte numbers were determined using 
acetic acid lysis solution (3% HEMA 3 solution II, 94% ddH2O, 3% gla-
cial acetic acid). Blood smears were prepared to corroborate monocyte 
numbers and subtract percent granulocytes from total leukocyte counts. 
Spleens were removed, triturated in HBSS (cellgro; Mediatech Inc.) at 
4°C with the end of a 3-ml syringe, and filtered through nylon mesh (BD 
Biosciences). Aortas were excised and placed into a cocktail of collage-
nase I, collagenase XI, DNase I, and hyaluronidase (Sigma-Aldrich) at 
37°C for 1 hour, as described previously (30). Cells were then triturated 
through nylon mesh. The cell suspensions were centrifuged (15 minutes, 
500 g, 4°C), red blood cells were lysed with ACK lysis buffer, and the 
resulting single-cell suspensions were washed with HBSS supplemented 
with 0.2% (w/v) BSA and 1% (w/v) FCS.
mAbs and flow cytometry. For visualization of monocytes, cells were incu-
bated with a cocktail of mAbs against T cells (CD90-PE, 53-2.1), B cells 
(B220-PE, RA3-6B2), NK cells (CD49b-PE, DX5 and NK1.1-PE, PK136), 
granulocytes (Ly-6G–PE, 1A8), myeloid cells (CD11b-APC, M1/70) and 
monocyte subsets (Ly-6C–FITC, AL-21). In Figure 1F, labeling with   
Ly-6C–biotin–strep–PerCP was performed so as to allow combination with   
CD11c-FITC (HL3) and CD62L-FITC (MEL-14). CD45.2-FITC and   
CD45.2-APC (A20) mAbs were also used (all from BD Biosciences). 
Monocytes were identified as CD11bhiCD90loB220loCD49bloNK1.1loLy-6Glo   
cells. F4/80 (BM8)-biotin-strep-PerCP, I-Ab (AF6-120.1)-biotin-strep-
PerCP and CD11c (HL3)-biotin-strep-PerCP mAbs also served to deter-
mine macrophage and dendritic cell differentiation. Monocyte numbers 
were calculated as total leukocytes (corrected for granulocyte content, as 
determined on blood smears) multiplied by percent cells within the mono-
cyte gate of the mononuclear cell fraction. Within this population, subsets 
were identified as either Ly-6Chi or Ly-6Clo. The number of cells in each 
subset was calculated by multiplying monocyte number by percent of cells 
in the subset. For proliferation studies, mice received 1 mg BrdU i.p. on 3 
consecutive days prior to sacrifice on day 4. Cells were stained with anti-
BrdU or annexin V, according to the manufacturer’s protocol (BD Bio-
sciences), and analyzed on a FACSCalibur or flow sorted on a FACSAria   
(all from BD Biosciences). For depletion of monocytes (24), mice were 
injected i.v. with 0.2 ml of dichloromethylene-bisphosphonate (clodronate)   
(Sigma-Aldrich) liposomes. Clodronate was incorporated into lipo-
somes, as previously described (53). For in vitro studies, cells were placed 
in complete medium (RPMI 1640 with 1 mM sodium pyruvate, 10 mM 
HEPES, 2 mM glutamine, 1% [w/v] penicillin/streptomycin and 10% [v/v]   
FCS previously heat inactivated for 1 hour at 56°C) alone or supplement-
ed with either 100 μg/ml AcLDL or 50 μg/ml M-CSF (R&D Systems). For 
morphologic characterizations, sorted cells were spun, resuspended in 
PBS, prepared on slides by cytocentrifugation (Shandon; Thermo Elec-
tron Corp.) at 10 g for 2 minutes, and stained with HEMA-3 (Biochemical 
Sciences Inc.). Monocytes were identified as cells 10–30 μm in diameter 
with a horseshoe- or kidney-shaped nucleus, a variable nucleus-to-cyto-
plasm ratio, and fine granules and vacuoli.
Mouse heart EC isolation. Mouse heart ECs (MHECs) were isolated and 
cultured from 7-day-old mice (54). Briefly, harvested tissues were digested 
with collagenase (Worthington Biochemical Corp.), and ECs were isolated 
with 2 rounds of magnetic bead purification (Invitrogen), the first with 
anti–PECAM-1 and the second with anti–ICAM-2 mAb (BD Biosciences).
Monocyte adhesion under defined laminar flow conditions. Monocytes 
from blood of apoE+/+ and apoE–/– mice were isolated. Interactions with 
MHECs were examined under conditions of fluid shear stress in a parallel 
plate flow chamber (55). Briefly, confluent MHECs were grown on glass 
coverslips (25-mm diameter; Carolina Biological Supply Co.) coated with 
5 μg/ml fibronectin (Sigma-Aldrich), stimulated with 120 ng/ml TNF-α 
for 4 hours, and inserted into the flow chamber. Monocytes (105 cells) 
were suspended in flow buffer (Dulbecco PBS, 0.75 mM Ca2+ and Mg2+, 
containing 0.1% human serum albumin) and drawn through the flow 
chamber as a bolus at an estimated shear stress of 0.76 dynes/cm2. Mono-
cyte accumulation was measured after 3 minutes of flow by counting 
stably adherent monocytes in 12–16 different fields. Monocyte-MHEC 
interactions were viewed using videomicroscopy (×20 phase-contrast 
objective) and digitally recorded to a PC using VideoLab software (ver-
sion 2.2.1; Ed Marcus Laboratories).
Immunohistochemistry. Aortas were excised, frozen in O.C.T. compound 
(Sakura), sectioned in 5-μm slices, and stained by the avidin-biotin-peroxi-
dase method as previously described (56). Cell types were identified with 
primary antibodies: monoclonal anti-CD31 (MEC 13.3) for endothelial 
cells, rat anti-mouse Mac-3 (M3/84) for macrophages, and anti–Ly-6C 
(AL-21) antibody to mouse macrophage precursor cells (BD Biosciences). 
Images were captured with a digital camera (Nikon DXM1200F) using 
imaging software ACT-1 (version 2.63; Nikon).
In vivo accumulation. Purified Ly-6Chi or Ly-6Clo monocytes from the 
spleen of apoE–/– or apoE–/– CCR2–/– mice were injected into apoE–/– 
CD45.1+/+ mice or labeled with [111In]oxine according to the manufac-
turer’s protocol (Amersham Biosciences). For imaging and autoradiog-
raphy experiments, cells were washed with HBSS, spun, and resuspended 
in [111In]oxine for 15 minutes at 37°C, pH 6.5–7.5. The cells were then 
washed twice with HBSS. This labeling protocol keeps the cells viable 
and in a resting state (16). Approximately 0.8 × 106 cells incorporating 
50 μCi were injected i.v. into apoE–/– mice fed Western diet for 50 weeks. 
The total amount of activity that was injected into each animal was mea-
sured with a radioisotope calibrator (Capintec Inc.). For flow cytometric 
studies, approximately 4 × 106 Ly-6Chi CD45.2 monocytes were injected 
to CD45.1+/+ apoE–/– mice fed Western diet for 50 weeks. After 24 hours, 
all animals were euthanized with CO2. Aortas were perfused in situ with 
10 ml HBSS via the left ventricle and excised from the root to the bifurca-
tion. All heart and fat tissue was excised to eliminate confounding sig-
nal. Aortas were then subjected to digestion (flow cytometric studies, see 
above). For radioactive studies, cpm for each aorta as well as blood were 
measured using a Wallac 1480 WIzARD gamma counter (PerkinElmer).   
Percent injected dose per gram tissue was calculated after correcting for research article
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decay, excretion, and tail radioactivity from occasional subtle extrava-
sations. Digital autoradiography was used with high-sensitivity screens 
and 50 μm readout (Phosphorimager Screen; Molecular Dynamics; GE 
HealthCare) for visualization of the spatial distribution of isotope-
labeled cells throughout the aorta. Accumulation was normalized to rela-
tive contribution of Ly-6Chi and Ly-6Clo monocytes in blood of apoE–/–   
mice fed Western diet.
Serum cholesterol measurement. At the time of sacrifice, blood was obtained 
by retroorbital bleeding. Serum was obtained by centrifugation at 16 g for 
15 minutes at 37°C. Serum cholesterol levels were measured using a cho-
lesterol kit (Hemagen Diagnostics Inc.).
Statistics. Data are expressed as mean ± SEM. Statistical tests included 
unpaired, 2-tailed Student’s t test using Welch’s correction for unequal 
variances and 1-way ANOVA with Tukey’s multiple comparison test. Sta-
tistical analyses were done using Prism. A P value of 0.05 or less was con-
sidered to be significant.
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